U.S. stocks rallied sharply Monday, driven by renewed appetite for AI-related equities and growing confidence that the Federal Reserve could deliver a December interest rate cut. At the close, the Dow Jones Industrial Average jumped 1.5%, the S&P 500 rose 1.4%, and the tech-heavy NASDAQ surged 2.7%. Despite the strong session, major indexes remain on track for a weak November, with the S&P 500 down 3.5% month-to-date, the NASDAQ lower by 6.1%, and the Dow off 2.8%.
Tech stocks led the recovery as Alphabet shares soared more than 6%. Investor enthusiasm grew after the company’s Gemini AI model received a significant upgrade, intensifying competition with OpenAI. A leaked memo suggested OpenAI CEO Sam Altman acknowledged Google’s momentum could create “temporary economic headwinds.” Other AI leaders, including NVIDIA and Oracle, also posted solid gains, reinforcing optimism around the sector’s long-term growth.
Rate-cut expectations strengthened after recent comments from key Federal Reserve officials. New York Fed President John Williams signaled support for a December cut, a stance echoed by Fed Governor Christopher Waller, who noted that economic conditions have not shifted meaningfully since the last policy meeting. According to the CME FedWatch Tool, the probability of a 25-basis-point cut has climbed to nearly 69%, up from 44% just a week ago.
Investors now await a wave of delayed U.S. economic data, including producer inflation, retail sales, industrial production, and third-quarter GDP. Signs of slowing growth or a cooling labor market could bolster the case for more easing, though the Fed will meet in December without November’s full payroll data.
Geopolitical sentiment also improved after President Trump accepted an invitation to meet Chinese President Xi Jinping in April, raising hopes of progress in U.S.–China trade relations.
In corporate news, Agilent Technologies is set to report earnings after the close, while Novo Nordisk shares tumbled following weak Alzheimer’s trial results. Biogen stock climbed as analysts suggested Novo Nordisk’s setback could boost Biogen’s Alzheimer’s drug Leqembi.


Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons
India Budget 2026: Modi Government Eyes Reforms Amid Global Uncertainty and Fiscal Pressures
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster
South Korea Factory Activity Hits 18-Month High as Export Demand Surges
Russia Stocks End Flat as MOEX Closes Unchanged Amid Mixed Global Signals
China Factory Activity Slips in January as Weak Demand Weighs on Growth Outlook
Wall Street Slides as Warsh Fed Nomination, Hot Inflation, and Precious Metals Rout Shake Markets
Dollar Holds Firm as Markets Weigh Warsh-Led Fed and Yen Weakness Ahead of Japan Election
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout
UK Employers Plan Moderate Pay Rises as Inflation Pressures Ease but Persist
Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry
U.S. Government Faces Brief Shutdown as Congress Delays Funding Deal
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data
South Korea Exports Surge in January on AI Chip Demand, Marking Fastest Growth in 4.5 Years
Oil Prices Slide Nearly 3% as U.S.-Iran Talks Ease Geopolitical Tensions
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions
Japan Election Poll Signals Landslide Win for Sanae Takaichi, Raising Fiscal Policy Concerns 



